Symbol:
Adora1
Name:
adenosine A1 receptor
RGD ID:
2048
Description:
Enables several functions, including G protein-coupled adenosine receptor activity; G-protein beta/gamma-subunit complex binding activity; and heterotrimeric G-protein binding activity. Involved in several processes, including modulation of chemical synaptic transmission; regulation of lipid catabolic process; and regulation of secretion. Located in several cellular components, including axon; basolateral plasma membrane; and presynaptic active zone. Is active in calyx of Held; postsynaptic membrane; and presynaptic membrane. Used to study cerebral infarction; hypertension; lung disease; and obstructive sleep apnea. Human ortholog(s) of this gene implicated in asthma. Orthologous to human ADORA1 (adenosine A1 receptor); INTERACTS WITH (+)-pilocarpine; (D-Ala(2)-mephe(4)-gly-ol(5))enkephalin; 1,4-dithiothreitol.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
adenosine receptor A1
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
ADORA1 (adenosine A1 receptor)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Adora1 (adenosine A1 receptor)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Adora1 (adenosine A1 receptor)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
ADORA1 (adenosine A1 receptor)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
ADORA1 (adenosine A1 receptor)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Adora1 (adenosine A1 receptor)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
ADORA1 (adenosine A1 receptor)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
ADORA1 (adenosine A1 receptor)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Adora1 (adenosine A1 receptor)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
DIABLO (diablo IAP-binding mitochondrial protein)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
ADORA1 (adenosine A1 receptor)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Adora1 (adenosine A1 receptor)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
adora1b (adenosine A1 receptor b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
AdoR
Alliance
DIOPT (Ensembl Compara|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
ador-1
Alliance
DIOPT (InParanoid|OrthoFinder|OrthoInspector|PANTHER)
Xenopus tropicalis (tropical clawed frog):
adora1
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Allele / Splice:
Adora1em3Mcwi
Adora1em4Mcwi
Genetic Models:
SS-Adora1em4Mcwi
SS-Adora1em3Mcwi
Candidate Gene For:
Bp328
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 13 48,210,922 - 48,247,826 (-) NCBI GRCr8 mRatBN7.2 13 45,658,872 - 45,695,821 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 13 45,658,872 - 45,695,801 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 13 48,270,569 - 48,302,744 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 13 49,558,626 - 49,590,806 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 13 46,823,488 - 46,855,595 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 13 51,042,111 - 51,076,913 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 51,042,248 - 51,076,852 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 13 56,097,883 - 56,132,155 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 47,160,292 - 47,192,804 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 13 47,173,084 - 47,207,198 (-) NCBI Celera 13 45,990,556 - 46,022,753 (-) NCBI Celera Cytogenetic Map 13 q13 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Adora1 Rat (+)-pilocarpine multiple interactions EXP 6480464 [2-chloro-N(6)cyclopentyladenosine binds to and results in increased activity of ADORA1 protein] which results in decreased susceptibility to Pilocarpine CTD PMID:11311893 Adora1 Rat (1->4)-beta-D-glucan multiple interactions ISO Adora1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ADORA1 mRNA CTD PMID:36331819 Adora1 Rat (D-Ala(2)-mephe(4)-gly-ol(5))enkephalin multiple interactions EXP 6480464 [1 more ... CTD PMID:8987795 Adora1 Rat 1,2-dichloroethane decreases expression ISO Adora1 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of ADORA1 mRNA CTD PMID:28189721 and PMID:28960355 Adora1 Rat 1,2-dimethylhydrazine multiple interactions ISO Adora1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADORA1 mRNA CTD PMID:22206623 Adora1 Rat 1,4-dithiothreitol multiple interactions EXP 6480464 [Dithiothreitol co-treated with Cadmium Chloride] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein] more ... CTD PMID:10413299 Adora1 Rat 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile multiple interactions ISO Adora1 (Mus musculus) 6480464 [Citalopram co-treated with Caffeine deficiency] results in increased expression of ADORA1 mRNA and [Citalopram co-treated with Caffeine] results in decreased expression of ADORA1 mRNA CTD PMID:29107002 Adora1 Rat 1-naphthyl isothiocyanate increases response to substance ISO Adora1 (Mus musculus) 6480464 ADORA1 protein results in increased susceptibility to 1-Naphthylisothiocyanate CTD PMID:22956627 Adora1 Rat 17beta-estradiol multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ADORA1 mRNA more ... CTD PMID:19698761 more ... Adora1 Rat 17beta-estradiol increases expression ISO Adora1 (Mus musculus) 6480464 Estradiol results in increased expression of ADORA1 mRNA CTD PMID:39298647 Adora1 Rat 17beta-estradiol increases expression ISO ADORA1 (Homo sapiens) 6480464 Estradiol results in increased expression of ADORA1 mRNA CTD PMID:23019147 more ... Adora1 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ADORA1 protein CTD PMID:18950269 Adora1 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Adora1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 Adora1 Rat 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Adora1 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 Adora1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Adora1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ADORA1 mRNA CTD PMID:19933214 Adora1 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Adora1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 Adora1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Adora1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADORA1 mRNA CTD PMID:18172886 more ... Adora1 Rat 3,3',5,5'-tetrabromobisphenol A increases expression ISO Adora1 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of ADORA1 mRNA CTD PMID:25172293 Adora1 Rat 3,4-methylenedioxymethamphetamine increases expression ISO Adora1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of ADORA1 mRNA CTD PMID:20188158 Adora1 Rat 4,4'-sulfonyldiphenol increases expression ISO Adora1 (Mus musculus) 6480464 bisphenol S results in increased expression of ADORA1 mRNA CTD PMID:39298647 Adora1 Rat 4,4'-sulfonyldiphenol affects methylation ISO Adora1 (Mus musculus) 6480464 bisphenol S affects the methylation of ADORA1 gene CTD PMID:31683443 Adora1 Rat 4,4'-sulfonyldiphenol increases methylation ISO Adora1 (Mus musculus) 6480464 bisphenol S results in increased methylation of ADORA1 exon CTD PMID:33297965 Adora1 Rat 4,4'-sulfonyldiphenol decreases methylation ISO ADORA1 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of ADORA1 gene CTD PMID:31601247 Adora1 Rat 4-hydroxynon-2-enal decreases expression ISO ADORA1 (Homo sapiens) 6480464 4-hydroxy-2-nonenal results in decreased expression of ADORA1 mRNA CTD PMID:12419474 Adora1 Rat 4-hydroxyphenyl retinamide increases expression ISO Adora1 (Mus musculus) 6480464 Fenretinide results in increased expression of ADORA1 mRNA CTD PMID:28973697 Adora1 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ADORA1 mRNA CTD PMID:24780913 Adora1 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ADORA1 mRNA CTD PMID:30047161 Adora1 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of ADORA1 mRNA CTD PMID:31881176 Adora1 Rat acetylsalicylic acid affects response to substance ISO ADORA1 (Homo sapiens) 6480464 ADORA1 polymorphism affects the susceptibility to Aspirin CTD PMID:19019667 Adora1 Rat adenosine multiple interactions ISO ADORA1 (Homo sapiens) 6480464 Adenosine analog binds to and affects the activity of ADORA1 protein more ... CTD PMID:18404447 and PMID:20571079 Adora1 Rat adenosine multiple interactions EXP 6480464 [lead acetate results in increased expression of ADORA1 protein] which results in increased abundance of Adenosine and Adenosine analog binds to and results in increased activity of ADORA1 protein CTD PMID:10649980 more ... Adora1 Rat adenosine affects binding ISO ADORA1 (Homo sapiens) 6480464 Adenosine binds to ADORA1 protein CTD PMID:18404447 Adora1 Rat aflatoxin B1 decreases methylation ISO ADORA1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of ADORA1 gene CTD PMID:27153756 Adora1 Rat aflatoxin B1 increases methylation ISO ADORA1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of ADORA1 intron CTD PMID:30157460 Adora1 Rat Aflatoxin B2 alpha increases methylation ISO ADORA1 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of ADORA1 intron CTD PMID:30157460 Adora1 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADORA1 mRNA CTD PMID:35163327 Adora1 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ADORA1 mRNA CTD PMID:16483693 Adora1 Rat arsane increases expression ISO Adora1 (Mus musculus) 6480464 Arsenic results in increased expression of ADORA1 mRNA CTD PMID:24019935 Adora1 Rat arsane multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADORA1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADORA1 mRNA CTD PMID:39836092 Adora1 Rat arsenic atom increases expression ISO Adora1 (Mus musculus) 6480464 Arsenic results in increased expression of ADORA1 mRNA CTD PMID:24019935 Adora1 Rat arsenic atom multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADORA1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADORA1 mRNA CTD PMID:39836092 Adora1 Rat arsenite(3-) multiple interactions ISO ADORA1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [arsenite results in increased expression of ADORA1 mRNA] CTD PMID:31646340 Adora1 Rat arsenite(3-) increases expression ISO ADORA1 (Homo sapiens) 6480464 arsenite results in increased expression of ADORA1 mRNA CTD PMID:31646340 Adora1 Rat benzalkonium chloride decreases expression ISO Adora1 (Mus musculus) 6480464 Benzalkonium Compounds results in decreased expression of ADORA1 mRNA CTD PMID:30171875 Adora1 Rat benzo[a]pyrene decreases expression ISO Adora1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ADORA1 mRNA CTD PMID:19770486 Adora1 Rat benzo[a]pyrene increases expression ISO ADORA1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of ADORA1 mRNA CTD PMID:32234424 Adora1 Rat benzo[a]pyrene affects methylation ISO ADORA1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of ADORA1 3' UTR CTD PMID:27901495 Adora1 Rat benzo[a]pyrene increases methylation ISO ADORA1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of ADORA1 promoter CTD PMID:27901495 Adora1 Rat benzo[a]pyrene decreases methylation ISO ADORA1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of ADORA1 5' UTR CTD PMID:27901495 Adora1 Rat benzo[a]pyrene increases expression ISO Adora1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ADORA1 mRNA CTD PMID:22228805 Adora1 Rat benzo[a]pyrene multiple interactions ISO Adora1 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ADORA1 mRNA] CTD PMID:22228805 Adora1 Rat bis(2-chloroethyl) sulfide increases expression ISO Adora1 (Mus musculus) 6480464 Mustard Gas results in increased expression of ADORA1 mRNA CTD PMID:15674843 Adora1 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Adora1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 Adora1 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Adora1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of ADORA1 mRNA CTD PMID:34319233 Adora1 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ADORA1 mRNA CTD PMID:25181051 Adora1 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ADORA1 mRNA CTD PMID:35192832 Adora1 Rat bisphenol A increases expression ISO ADORA1 (Homo sapiens) 6480464 bisphenol A analog results in increased expression of ADORA1 mRNA and bisphenol A results in increased expression of ADORA1 mRNA CTD PMID:32387340 Adora1 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ADORA1 gene CTD PMID:28505145 Adora1 Rat bisphenol A multiple interactions ISO Adora1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 Adora1 Rat bisphenol A increases expression ISO Adora1 (Mus musculus) 6480464 bisphenol A results in increased expression of ADORA1 mRNA CTD PMID:25594700 and PMID:34585602 Adora1 Rat Bisphenol B increases expression ISO ADORA1 (Homo sapiens) 6480464 bisphenol B results in increased expression of ADORA1 mRNA CTD PMID:32387340 Adora1 Rat bisphenol F multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of ADORA1 gene CTD PMID:31601247 Adora1 Rat bisphenol F increases expression ISO Adora1 (Mus musculus) 6480464 bisphenol F results in increased expression of ADORA1 mRNA CTD PMID:38685157 Adora1 Rat Bisphenol Z increases expression ISO ADORA1 (Homo sapiens) 6480464 bisphenol Z results in increased expression of ADORA1 mRNA CTD PMID:32387340 Adora1 Rat butanal increases expression ISO ADORA1 (Homo sapiens) 6480464 butyraldehyde results in increased expression of ADORA1 mRNA CTD PMID:26079696 Adora1 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of ADORA1 mRNA CTD PMID:19167457 Adora1 Rat cadmium atom increases expression ISO ADORA1 (Homo sapiens) 6480464 Cadmium results in increased expression of ADORA1 mRNA CTD PMID:31646340 Adora1 Rat cadmium atom multiple interactions ISO ADORA1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Cadmium results in increased expression of ADORA1 mRNA] CTD PMID:31646340 Adora1 Rat cadmium dichloride multiple interactions EXP 6480464 [Dithiothreitol co-treated with Cadmium Chloride] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein] more ... CTD PMID:10413299 Adora1 Rat cadmium dichloride increases expression ISO ADORA1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of ADORA1 mRNA CTD PMID:38568856 Adora1 Rat caffeine decreases activity EXP 6480464 Caffeine results in decreased activity of ADORA1 protein CTD PMID:15708489 Adora1 Rat caffeine decreases expression ISO Adora1 (Mus musculus) 6480464 Caffeine deficiency results in decreased expression of ADORA1 mRNA CTD PMID:29107002 Adora1 Rat caffeine decreases activity ISO ADORA1 (Homo sapiens) 6480464 Caffeine results in decreased activity of ADORA1 protein CTD PMID:23611293 Adora1 Rat caffeine decreases activity ISO Adora1 (Mus musculus) 6480464 Caffeine results in decreased activity of ADORA1 protein CTD PMID:22164264 Adora1 Rat caffeine multiple interactions EXP 6480464 Caffeine inhibits the reaction [N(6)-cyclopentyladenosine binds to and results in increased activity of ADORA1 protein] and Caffeine promotes the reaction [Phenylisopropyladenosine binds to and results in increased activity of ADORA1 protein] CTD PMID:10401785 and PMID:3003150 Adora1 Rat caffeine increases expression ISO Adora1 (Mus musculus) 6480464 Caffeine results in increased expression of ADORA1 protein CTD PMID:7996441 Adora1 Rat caffeine multiple interactions ISO Adora1 (Mus musculus) 6480464 [8-cyclopentyl-1 more ... CTD PMID:29107002 more ... Adora1 Rat caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of ADORA1 mRNA CTD PMID:12153486 Adora1 Rat calcitriol multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ADORA1 mRNA CTD PMID:21592394 Adora1 Rat calcitriol decreases expression ISO ADORA1 (Homo sapiens) 6480464 Calcitriol results in decreased expression of ADORA1 mRNA CTD PMID:21592394 Adora1 Rat carbon nanotube affects expression ISO Adora1 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of ADORA1 mRNA CTD PMID:23845593 and PMID:25620056 Adora1 Rat carbon nanotube increases expression ISO Adora1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Adora1 Rat carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of ADORA1 mRNA CTD PMID:19395590 Adora1 Rat CGP 52608 multiple interactions ISO ADORA1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to ADORA1 gene] CTD PMID:28238834 Adora1 Rat chlordecone increases expression ISO Adora1 (Mus musculus) 6480464 Chlordecone results in increased expression of ADORA1 mRNA CTD PMID:33711761 Adora1 Rat citalopram multiple interactions ISO Adora1 (Mus musculus) 6480464 [Citalopram co-treated with Caffeine deficiency] results in increased expression of ADORA1 mRNA and [Citalopram co-treated with Caffeine] results in decreased expression of ADORA1 mRNA CTD PMID:29107002 Adora1 Rat clofibrate multiple interactions ISO Adora1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ADORA1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ADORA1 mRNA] CTD PMID:17585979 Adora1 Rat clonidine multiple interactions EXP 6480464 [1 and 3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine binds to and results in decreased activity of ADORA1 protein] which results in decreased susceptibility to Clonidine CTD PMID:8987795 Adora1 Rat clonidine (amino form) multiple interactions EXP 6480464 [1 and 3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine binds to and results in decreased activity of ADORA1 protein] which results in decreased susceptibility to Clonidine CTD PMID:8987795 Adora1 Rat clonidine (imino form) multiple interactions EXP 6480464 [1 and 3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine binds to and results in decreased activity of ADORA1 protein] which results in decreased susceptibility to Clonidine CTD PMID:8987795 Adora1 Rat cobalt dichloride multiple interactions ISO Adora1 (Mus musculus) 6480464 [1 and 3-dipropyl-8-cyclopentylxanthine binds to and results in decreased activity of ADORA1 protein] which results in increased susceptibility to cobaltous chloride CTD PMID:18727925 Adora1 Rat cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ADORA1 mRNA CTD PMID:24386269 Adora1 Rat cobalt dichloride decreases response to substance ISO Adora1 (Mus musculus) 6480464 ADORA1 protein results in decreased susceptibility to cobaltous chloride CTD PMID:18727925 Adora1 Rat cocaine affects expression EXP 6480464 Cocaine affects the expression of ADORA1 mRNA and Cocaine affects the expression of ADORA1 protein CTD PMID:12358776 Adora1 Rat cocaine affects response to substance ISO Adora1 (Mus musculus) 6480464 ADORA1 affects the susceptibility to Cocaine CTD PMID:19092996 Adora1 Rat corticosterone decreases expression ISO Adora1 (Mus musculus) 6480464 Corticosterone results in decreased expression of ADORA1 mRNA CTD PMID:31344373 Adora1 Rat corticosterone multiple interactions ISO Adora1 (Mus musculus) 6480464 Edaravone inhibits the reaction [Corticosterone results in decreased expression of ADORA1 mRNA] CTD PMID:31344373 Adora1 Rat cytidine increases activity EXP 6480464 Cytidine results in increased activity of ADORA1 protein CTD PMID:18313046 Adora1 Rat diallyl disulfide multiple interactions ISO ADORA1 (Homo sapiens) 6480464 diallyl disulfide inhibits the reaction [tobacco tar analog results in decreased expression of ADORA1 mRNA] CTD PMID:36758788 Adora1 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ADORA1 mRNA CTD PMID:15620428 Adora1 Rat dibutyl phthalate decreases expression ISO Adora1 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of ADORA1 mRNA CTD PMID:17361019 and PMID:21266533 Adora1 Rat diethyl pyrocarbonate multiple interactions EXP 6480464 Diethyl Pyrocarbonate inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein] CTD PMID:10413299 Adora1 Rat diethylstilbestrol increases expression ISO ADORA1 (Homo sapiens) 6480464 Diethylstilbestrol results in increased expression of ADORA1 mRNA CTD PMID:15766595 Adora1 Rat diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of ADORA1 mRNA CTD PMID:37077353 Adora1 Rat dioxygen multiple interactions ISO Adora1 (Mus musculus) 6480464 [1 and 3-dipropyl-8-cyclopentylxanthine binds to and results in decreased activity of ADORA1 protein] which results in decreased susceptibility to Oxygen deficiency CTD PMID:23437309 Adora1 Rat dithionitrobenzoic acid multiple interactions EXP 6480464 [Dithiothreitol co-treated with Dithionitrobenzoic Acid] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein] more ... CTD PMID:10413299 Adora1 Rat dopamine multiple interactions EXP 6480464 [N(6)-cyclohexyladenosine binds to and results in increased activity of ADORA1 protein] promotes the reaction [Methamphetamine results in increased secretion of Dopamine] CTD PMID:11043458 Adora1 Rat dorsomorphin multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Adora1 Rat doxorubicin decreases expression ISO ADORA1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ADORA1 mRNA CTD PMID:29803840 Adora1 Rat DPCPX affects binding ISO ADORA1 (Homo sapiens) 6480464 1 and 3-dipropyl-8-cyclopentylxanthine binds to ADORA1 protein CTD PMID:21186795 and PMID:21675777 Adora1 Rat DPCPX multiple interactions EXP 6480464 1 more ... CTD PMID:10642308 more ... Adora1 Rat DPCPX multiple interactions ISO Adora1 (Mus musculus) 6480464 1 more ... CTD PMID:18727925 more ... Adora1 Rat edaravone multiple interactions ISO Adora1 (Mus musculus) 6480464 Edaravone inhibits the reaction [Corticosterone results in decreased expression of ADORA1 mRNA] CTD PMID:31344373 Adora1 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ADORA1 mRNA CTD PMID:29391264 Adora1 Rat endosulfan affects expression EXP 6480464 Endosulfan affects the expression of ADORA1 mRNA CTD PMID:31464424 Adora1 Rat ethanol multiple interactions ISO Adora1 (Mus musculus) 6480464 [ADORA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased expression of ACACA mRNA more ... CTD PMID:23692951 Adora1 Rat ethanol increases expression ISO Adora1 (Mus musculus) 6480464 Ethanol results in increased expression of ADORA1 mRNA CTD PMID:35143882 Adora1 Rat ethanol affects splicing ISO Adora1 (Mus musculus) 6480464 Ethanol affects the splicing of ADORA1 mRNA CTD PMID:30319688 Adora1 Rat ethanol increases response to substance ISO Adora1 (Mus musculus) 6480464 ADORA1 gene mutant form results in increased susceptibility to Ethanol CTD PMID:23692951 Adora1 Rat fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of ADORA1 mRNA CTD PMID:30307764 Adora1 Rat fluoxetine multiple interactions ISO Adora1 (Mus musculus) 6480464 [Fluoxetine co-treated with Caffeine deficiency] results in increased expression of ADORA1 mRNA CTD PMID:29107002 Adora1 Rat folic acid multiple interactions ISO Adora1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADORA1 mRNA CTD PMID:22206623 Adora1 Rat fulvestrant decreases expression ISO ADORA1 (Homo sapiens) 6480464 Fulvestrant results in decreased expression of ADORA1 mRNA CTD PMID:31646340 Adora1 Rat fulvestrant multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of ADORA1 gene more ... CTD PMID:31601247 and PMID:31646340 Adora1 Rat furan increases expression EXP 6480464 furan results in increased expression of ADORA1 mRNA CTD PMID:26194646 Adora1 Rat gamma-aminobutyric acid decreases expression EXP 6480464 gamma-Aminobutyric Acid results in decreased expression of ADORA1 mRNA CTD PMID:26924987 Adora1 Rat gefitinib decreases expression ISO ADORA1 (Homo sapiens) 6480464 gefitinib results in decreased expression of ADORA1 mRNA CTD PMID:16685379 Adora1 Rat glycerol affects expression EXP 6480464 Glycerol affects the expression of ADORA1 protein CTD PMID:10677590 Adora1 Rat hydrogen peroxide decreases expression ISO ADORA1 (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of ADORA1 mRNA CTD PMID:12419474 Adora1 Rat hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of ADORA1 mRNA CTD PMID:35901927 Adora1 Rat Indeno[1,2,3-cd]pyrene decreases expression ISO ADORA1 (Homo sapiens) 6480464 indeno(1 more ... CTD PMID:32251684 Adora1 Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of ADORA1 mRNA CTD PMID:21396975 Adora1 Rat ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of ADORA1 mRNA CTD PMID:37077353 Adora1 Rat L-1,4-dithiothreitol multiple interactions EXP 6480464 [Dithiothreitol co-treated with Cadmium Chloride] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein] more ... CTD PMID:10413299 Adora1 Rat L-cysteine multiple interactions EXP 6480464 Cysteine inhibits the reaction [Cadmium Chloride inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]] CTD PMID:10413299 Adora1 Rat lead diacetate multiple interactions EXP 6480464 [lead acetate co-treated with Morphine] results in increased expression of ADORA1 mRNA more ... CTD PMID:20932874 and PMID:26478469 Adora1 Rat lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of ADORA1 mRNA and lead acetate results in increased expression of ADORA1 protein CTD PMID:20932874 and PMID:26478469 Adora1 Rat lead(0) decreases expression ISO ADORA1 (Homo sapiens) 6480464 Lead results in decreased expression of ADORA1 mRNA CTD PMID:19921347 Adora1 Rat lipopolysaccharide multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ADORA1 mRNA CTD PMID:35811015 Adora1 Rat maneb multiple interactions ISO Adora1 (Mus musculus) 6480464 [SNCA protein co-treated with Maneb co-treated with Paraquat] results in decreased expression of ADORA1 mRNA CTD PMID:23017109 Adora1 Rat manganese atom multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADORA1 mRNA CTD PMID:39836092 Adora1 Rat manganese(0) multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADORA1 mRNA CTD PMID:39836092 Adora1 Rat manganese(II) chloride multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADORA1 mRNA CTD PMID:39836092 Adora1 Rat mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of ADORA1 protein CTD PMID:10677590 Adora1 Rat methamphetamine multiple interactions ISO Adora1 (Mus musculus) 6480464 [8-cyclopentyl-1 more ... CTD PMID:7996441 Adora1 Rat methamphetamine multiple interactions EXP 6480464 [N(6)-cyclohexyladenosine binds to and results in increased activity of ADORA1 protein] promotes the reaction [Methamphetamine results in increased secretion of Dopamine] and [N(6)-cyclohexyladenosine binds to and results in increased activity of ADORA1 protein] which results in increased susceptibility to Methamphetamine CTD PMID:11043458 Adora1 Rat methylmercury chloride decreases expression ISO ADORA1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of ADORA1 mRNA CTD PMID:28001369 Adora1 Rat mianserin multiple interactions ISO Adora1 (Mus musculus) 6480464 [Caffeine co-treated with Mianserin] results in decreased expression of ADORA1 mRNA CTD PMID:29882086 Adora1 Rat mono(2-ethylhexyl) phthalate decreases expression ISO Adora1 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of ADORA1 mRNA CTD PMID:22401849 Adora1 Rat monosodium L-glutamate multiple interactions ISO Adora1 (Mus musculus) 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ADORA1 mRNA CTD PMID:19001666 Adora1 Rat morphine affects response to substance ISO Adora1 (Mus musculus) 6480464 ADORA1 protein affects the susceptibility to Morphine CTD PMID:9407998 Adora1 Rat morphine increases expression EXP 6480464 Morphine results in increased expression of ADORA1 mRNA and Morphine results in increased expression of ADORA1 protein CTD PMID:26478469 Adora1 Rat morphine multiple interactions EXP 6480464 [lead acetate co-treated with Morphine] results in increased expression of ADORA1 mRNA and [lead acetate co-treated with Morphine] results in increased expression of ADORA1 protein CTD PMID:26478469 Adora1 Rat N-methyl-4-phenylpyridinium affects expression ISO ADORA1 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium affects the expression of ADORA1 mRNA CTD PMID:12710931 Adora1 Rat nickel atom decreases expression ISO ADORA1 (Homo sapiens) 6480464 Nickel results in decreased expression of ADORA1 mRNA CTD PMID:25583101 Adora1 Rat orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of ADORA1 mRNA CTD PMID:23665939 Adora1 Rat ozone increases expression EXP 6480464 Ozone results in increased expression of ADORA1 mRNA CTD PMID:28623178 Adora1 Rat paracetamol multiple interactions ISO Adora1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ADORA1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ADORA1 mRNA] CTD PMID:17585979 Adora1 Rat paracetamol decreases expression ISO ADORA1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ADORA1 mRNA CTD PMID:26690555 Adora1 Rat paraquat multiple interactions ISO Adora1 (Mus musculus) 6480464 [SNCA protein co-treated with Maneb co-treated with Paraquat] results in decreased expression of ADORA1 mRNA CTD PMID:23017109 Adora1 Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of ADORA1 mRNA CTD PMID:32680482 Adora1 Rat pentachlorophenol increases expression ISO Adora1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of ADORA1 mRNA CTD PMID:23892564 Adora1 Rat perfluorooctane-1-sulfonic acid affects expression ISO Adora1 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of ADORA1 mRNA CTD PMID:19429403 Adora1 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Adora1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ADORA1 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ADORA1 mRNA CTD PMID:36331819 Adora1 Rat perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of ADORA1 mRNA CTD PMID:20136073 Adora1 Rat perfluorooctanoic acid affects expression ISO Adora1 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of ADORA1 mRNA CTD PMID:19429403 Adora1 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADORA1 mRNA CTD PMID:35163327 Adora1 Rat phenylephrine multiple interactions EXP 6480464 1 more ... CTD PMID:19966059 Adora1 Rat phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of ADORA1 mRNA and Phenylephrine results in increased expression of ADORA1 protein CTD PMID:19966059 Adora1 Rat phenylmercury acetate decreases expression ISO ADORA1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of ADORA1 mRNA CTD PMID:26272509 Adora1 Rat phenylmercury acetate multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADORA1 mRNA CTD PMID:27188386 Adora1 Rat picene decreases expression ISO ADORA1 (Homo sapiens) 6480464 picene results in decreased expression of ADORA1 mRNA CTD PMID:32251684 Adora1 Rat pioglitazone multiple interactions ISO Adora1 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADORA1 mRNA CTD PMID:27935865 Adora1 Rat prazosin multiple interactions EXP 6480464 Prazosin inhibits the reaction [Phenylephrine results in increased expression of ADORA1 protein] CTD PMID:19966059 Adora1 Rat resveratrol multiple interactions EXP 6480464 [8-cyclopentyl-1 more ... CTD PMID:15345477 Adora1 Rat resveratrol multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADORA1 mRNA CTD PMID:23557933 Adora1 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ADORA1 mRNA CTD PMID:35811015 Adora1 Rat sarin increases expression ISO ADORA1 (Homo sapiens) 6480464 Sarin results in increased expression of ADORA1 mRNA CTD PMID:19522546 Adora1 Rat SB 431542 multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Adora1 Rat sodium arsenite decreases expression ISO ADORA1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of ADORA1 mRNA CTD PMID:38568856 Adora1 Rat sodium arsenite increases expression ISO Adora1 (Mus musculus) 6480464 sodium arsenite results in increased expression of ADORA1 mRNA CTD PMID:37682722 Adora1 Rat sodium arsenite multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADORA1 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADORA1 mRNA CTD PMID:39836092 Adora1 Rat sodium arsenite increases expression ISO ADORA1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of ADORA1 mRNA CTD PMID:34032870 Adora1 Rat sunitinib decreases expression ISO ADORA1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of ADORA1 mRNA CTD PMID:31533062 Adora1 Rat tamoxifen affects expression ISO Adora1 (Mus musculus) 6480464 Tamoxifen affects the expression of ADORA1 mRNA CTD PMID:20937368 Adora1 Rat tert-butyl hydroperoxide decreases expression ISO ADORA1 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of ADORA1 mRNA CTD PMID:12419474 Adora1 Rat testosterone multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ADORA1 mRNA CTD PMID:21592394 Adora1 Rat testosterone decreases expression ISO ADORA1 (Homo sapiens) 6480464 Testosterone results in decreased expression of ADORA1 mRNA CTD PMID:21592394 Adora1 Rat tetrachloromethane increases expression ISO Adora1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ADORA1 mRNA CTD PMID:18263696 Adora1 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ADORA1 protein CTD PMID:12629582 Adora1 Rat tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of ADORA1 mRNA CTD PMID:12734012 Adora1 Rat tetraphene increases expression ISO Adora1 (Mus musculus) 6480464 benz(a)anthracene results in increased expression of ADORA1 mRNA CTD PMID:26377693 Adora1 Rat theophylline decreases activity EXP 6480464 Theophylline results in decreased activity of ADORA1 protein CTD PMID:15708489 Adora1 Rat theophylline decreases expression EXP 6480464 Theophylline results in decreased expression of ADORA1 mRNA CTD PMID:12153486 Adora1 Rat theophylline multiple interactions EXP 6480464 Theophylline binds to and results in decreased activity of ADORA1 protein CTD PMID:14992338 and PMID:9535120 Adora1 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ADORA1 mRNA CTD PMID:23411599 and PMID:34492290 Adora1 Rat titanium dioxide increases expression ISO Adora1 (Mus musculus) 6480464 titanium dioxide results in increased expression of ADORA1 mRNA CTD PMID:21259345 more ... Adora1 Rat titanium dioxide decreases methylation ISO Adora1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of ADORA1 gene and titanium dioxide results in decreased methylation of ADORA1 promoter CTD PMID:35295148 Adora1 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ADORA1 mRNA CTD PMID:33387578 Adora1 Rat trichostatin A decreases expression ISO ADORA1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of ADORA1 mRNA CTD PMID:24935251 Adora1 Rat triclosan decreases expression ISO ADORA1 (Homo sapiens) 6480464 Triclosan results in decreased expression of ADORA1 mRNA CTD PMID:30510588 Adora1 Rat uridine increases activity EXP 6480464 Uridine results in increased activity of ADORA1 protein CTD PMID:18313046 Adora1 Rat valproic acid decreases methylation ISO ADORA1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of ADORA1 gene CTD PMID:29154799 Adora1 Rat valproic acid multiple interactions ISO ADORA1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADORA1 mRNA CTD PMID:27188386 Adora1 Rat valproic acid decreases expression ISO ADORA1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ADORA1 mRNA CTD PMID:23179753 more ... Adora1 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ADORA1 mRNA CTD PMID:23034163 Adora1 Rat XL147 multiple interactions ISO Adora1 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADORA1 mRNA CTD PMID:27935865 Adora1 Rat zinc dichloride multiple interactions EXP 6480464 zinc chloride inhibits the reaction [N(6)-cyclohexyladenosine binds to ADORA1 protein] CTD PMID:10413299
asthma (ISO) Bradycardia (ISO) Brain Hypoxia-Ischemia (IEP) Catalepsy (ISO) cerebral infarction (IDA) Diabetic Nephropathies (IMP) drug allergy (ISO) Drug-Related Side Effects and Adverse Reactions (ISO) Experimental Diabetes Mellitus (IDA,IEP,ISO) familial adult myoclonic epilepsy 5 (ISO) gastrointestinal stromal tumor (ISO) Genetic Predisposition to Disease (ISO) Hyperalgesia (IDA) hypertension (IDA,IMP,ISO) Hypokalemic Periodic Paralysis, Type 1 (ISO) Hypotension (ISO) Inflammation (IDA) Insulin Resistance (IDA,ISO) ischemia (ISO) lung disease (IDA,ISO) middle cerebral artery infarction (ISO) myocardial infarction (ISO) Nerve Degeneration (ISO) obesity (ISO) obstructive sleep apnea (IMP) panic disorder (ISO) parathyroid carcinoma (ISO) Paroxysmal Dyspnea (ISO) pneumonia (ISO) Prenatal Exposure Delayed Effects (ISO) Spinal Cord Injuries (IDA,IEP,IMP) Subarachnoid Hemorrhage (ISO) transient cerebral ischemia (ISO) Ventricular Dysfunction (ISO) Ventricular Dysfunction, Left (IEP) Ventricular Fibrillation (IDA) Ventriculomegaly (IDA) withdrawal disorder (ISO)
(+)-pilocarpine (EXP) (1->4)-beta-D-glucan (ISO) (D-Ala(2)-mephe(4)-gly-ol(5))enkephalin (EXP) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 1,4-dithiothreitol (EXP) 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile (ISO) 1-naphthyl isothiocyanate (ISO) 17beta-estradiol (EXP,ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 3,4-methylenedioxymethamphetamine (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxynon-2-enal (ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (EXP) acetamide (EXP) acetylsalicylic acid (ISO) adenosine (EXP,ISO) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) alpha-Zearalanol (EXP) ammonium chloride (EXP) arsane (ISO) arsenic atom (ISO) arsenite(3-) (ISO) benzalkonium chloride (ISO) benzo[a]pyrene (ISO) bis(2-chloroethyl) sulfide (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) Bisphenol B (ISO) bisphenol F (ISO) Bisphenol Z (ISO) butanal (ISO) C60 fullerene (EXP) cadmium atom (ISO) cadmium dichloride (EXP,ISO) caffeine (EXP,ISO) calcitriol (ISO) carbon nanotube (ISO) carbonyl sulfide (EXP) CGP 52608 (ISO) chlordecone (ISO) citalopram (ISO) clofibrate (ISO) clonidine (EXP) clonidine (amino form) (EXP) clonidine (imino form) (EXP) cobalt dichloride (EXP,ISO) cocaine (EXP,ISO) corticosterone (ISO) cytidine (EXP) diallyl disulfide (ISO) dibutyl phthalate (EXP,ISO) diethyl pyrocarbonate (EXP) diethylstilbestrol (EXP,ISO) dioxygen (ISO) dithionitrobenzoic acid (EXP) dopamine (EXP) dorsomorphin (ISO) doxorubicin (ISO) DPCPX (EXP,ISO) edaravone (ISO) endosulfan (EXP) ethanol (ISO) fenvalerate (EXP) fluoxetine (ISO) folic acid (ISO) fulvestrant (ISO) furan (EXP) gamma-aminobutyric acid (EXP) gefitinib (ISO) glycerol (EXP) hydrogen peroxide (EXP,ISO) Indeno[1,2,3-cd]pyrene (ISO) indole-3-methanol (EXP) ketoconazole (EXP) L-1,4-dithiothreitol (EXP) L-cysteine (EXP) lead diacetate (EXP) lead(0) (ISO) lipopolysaccharide (ISO) maneb (ISO) manganese atom (ISO) manganese(0) (ISO) manganese(II) chloride (ISO) mercury dichloride (EXP) methamphetamine (EXP,ISO) methylmercury chloride (ISO) mianserin (ISO) mono(2-ethylhexyl) phthalate (ISO) monosodium L-glutamate (ISO) morphine (EXP,ISO) N-methyl-4-phenylpyridinium (ISO) nickel atom (ISO) orphenadrine (EXP) ozone (EXP) paracetamol (ISO) paraquat (EXP,ISO) pentachlorophenol (ISO) perfluorooctane-1-sulfonic acid (EXP,ISO) perfluorooctanoic acid (EXP,ISO) phenylephrine (EXP) phenylmercury acetate (ISO) picene (ISO) pioglitazone (ISO) prazosin (EXP) resveratrol (EXP,ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) sarin (ISO) SB 431542 (ISO) sodium arsenite (ISO) sunitinib (ISO) tamoxifen (ISO) tert-butyl hydroperoxide (ISO) testosterone (ISO) tetrachloromethane (EXP,ISO) tetraphene (ISO) theophylline (EXP) thioacetamide (EXP) titanium dioxide (ISO) trichloroethene (EXP) trichostatin A (ISO) triclosan (ISO) uridine (EXP) valproic acid (ISO) vinclozolin (EXP) XL147 (ISO) zinc dichloride (EXP)
Biological Process
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (IMP) cognition (IMP) detection of temperature stimulus involved in sensory perception of pain (IMP) excitatory postsynaptic potential (IEA,IMP,ISO) fatty acid homeostasis (IDA) G protein-coupled adenosine receptor signaling pathway (IEA) G protein-coupled purinergic nucleotide receptor signaling pathway (IDA) G protein-coupled receptor signaling pathway (IBA,IDA,IEA) leukocyte migration (IEA,ISO) lipid catabolic process (IMP) long-term synaptic depression (IEA,ISO) mucus secretion (IEA,ISO) negative regulation of acute inflammatory response (IDA) negative regulation of apoptotic process (IDA) negative regulation of blood pressure (IMP) negative regulation of cell population proliferation (IDA) negative regulation of circadian sleep/wake cycle, non-REM sleep (IMP) negative regulation of circadian sleep/wake cycle, sleep (IDA) negative regulation of glutamate secretion (IDA) negative regulation of hormone secretion (IMP) negative regulation of inflammatory response (IEA,ISO) negative regulation of leukocyte migration (IEA,ISO) negative regulation of lipid catabolic process (IDA) negative regulation of long-term synaptic depression (IEA,ISO) negative regulation of long-term synaptic potentiation (IMP) negative regulation of mucus secretion (IEA,ISO) negative regulation of neurotrophin production (IMP) negative regulation of synaptic transmission, GABAergic (IDA,IMP) negative regulation of synaptic transmission, glutamatergic (IDA) negative regulation of systemic arterial blood pressure (IDA) positive regulation of blood pressure (IDA) positive regulation of dephosphorylation (IDA) positive regulation of epidermal growth factor-activated receptor activity (IMP) positive regulation of lipid catabolic process (IDA) positive regulation of MAPK cascade (IDA) positive regulation of nucleoside transport (IDA) positive regulation of peptide secretion (IMP) positive regulation of potassium ion transport (IDA) positive regulation of systemic arterial blood pressure (IMP) protein targeting to membrane (IMP) regulation of cardiac muscle cell contraction (IDA) regulation of cardiac muscle contraction (IMP) regulation of cell communication (IEA) regulation of glomerular filtration (IEA,ISO) regulation of presynaptic cytosolic calcium ion concentration (EXP,IDA) regulation of respiratory gaseous exchange by nervous system process (IMP) regulation of sensory perception of pain (IEA,ISO) regulation of signaling (IEA) response to auditory stimulus (ISO) response to hypoxia (IMP) response to purine-containing compound (IEA,ISO) signal transduction (IEA) temperature homeostasis (IMP) triglyceride homeostasis (IDA) vasoconstriction (ISO) vasodilation (IDA)
1.
Ischaemic and pharmacological preconditionings protect liver via adenosine and redox status following hepatic ischaemia/reperfusion in rats.
Ajamieh HH, etal., Clin Sci (Lond). 2008 Jul;115(2):69-77.
2.
Moderate cerebral venous congestion induces rapid cerebral protection via adenosine A1 receptor activation.
Akaiwa K, etal., Brain Res. 2006 Nov 29;1122(1):47-55. Epub 2006 Oct 24.
3.
Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices.
Almeida T, etal., Neuroscience. 2003;122(1):111-21.
4.
Revista española de cardiología
Alvarado-Tapias E, etal., Rev Esp Cardiol. 2010 Apr;63(4):478-82.
5.
Effects of the adenosine A1 receptor inhibitor FK 838 on proximal tubular fluid output in rats.
Bak M and Thomsen K, Nephrol Dial Transplant. 2004 May;19(5):1077-82. Epub 2004 Feb 19.
6.
Protective effect of adenosine in diabetic neuropathic pain is mediated through adenosine A1-receptors.
Balasubramanyan S and Sharma SS, Indian J Physiol Pharmacol. 2008 Jul-Sep;52(3):233-42.
7.
Differences in the expression of the adenosine A1 receptor in adipose tissue of obese black and white women.
Barakat H, etal., J Clin Endocrinol Metab. 2006 May;91(5):1882-6. Epub 2006 Feb 28.
8.
Respiratory and body temperature modulation by adenosine A1 receptors in the anteroventral preoptic region during normoxia and hypoxia.
Barros RC, etal., Respir Physiol Neurobiol. 2006 Sep 28;153(2):115-25. Epub 2005 Dec 13.
9.
Tumor necrosis factor-alpha impairs the recovery of synaptic transmission from hypoxia in rat hippocampal slices.
Batti L and O'Connor JJ, J Neuroimmunol. 2010 Jan 25;218(1-2):21-7. Epub 2009 Nov 25.
10.
The genetic association database.
Becker KG, etal., Nat Genet. 2004 May;36(5):431-2.
11.
Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects.
Brown RA, etal., Eur Respir J. 2008 Feb;31(2):311-9. Epub 2007 Oct 24.
12.
Activation of adenosine A1 receptors by drugs to lower plasma glucose in streptozotocin-induced diabetic rats.
Cheng JT, etal., Auton Neurosci. 2000 Oct 2;83(3):127-33.
13.
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers.
Ciruela F, etal., J Neurosci. 2006 Feb 15;26(7):2080-7.
14.
Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance.
Dong Q, etal., Diabetes Obes Metab. 2001 Oct;3(5):360-6.
15.
Modification of adenosine A1 and A2A receptor density in the hippocampus of streptozotocin-induced diabetic rats.
Duarte JM, etal., Neurochem Int. 2006 Jan;48(2):144-50. Epub 2005 Oct 26.
16.
ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.
Duflot S, etal., Mol Cell Biol. 2004 Apr;24(7):2710-9.
17.
Adenoprotection of the heart involves phospholipase C-induced activation and translocation of PKC-epsilon to RACK2 in adult rat and mouse.
Fenton RA, etal., Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H718-25. Epub 2009 Jun 12.
18.
Regulation of ATP-sensitive K+ channels by caveolin-enriched microdomains in cardiac myocytes.
Garg V, etal., Cardiovasc Res. 2009 Apr 1;82(1):51-8. doi: 10.1093/cvr/cvp039. Epub 2009 Jan 30.
19.
The role of the basal forebrain adenosine receptors in sleep homeostasis.
Gass N, etal., Neuroreport. 2009 Jul 15;20(11):1013-8.
20.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
21.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
22.
Study of an adenosine A1 receptor agonist on trigeminally evoked dural blood vessel dilation in the anaesthetized rat.
Honey AC, etal., Cephalalgia. 2002 May;22(4):260-4.
23.
Adenosine A1 receptor agonists reduce hyperalgesia after spinal cord injury in rats.
Horiuchi H, etal., Spinal Cord. 2010 Sep;48(9):685-90. Epub 2010 Jan 12.
24.
Hypoglycemic and hypotensive effects of 6-cyclohexyl-2'-O-methyl-adenosine, an adenosine A1 receptor agonist, in spontaneously hypertensive rat complicated with hyperglycemia.
Ishikawa J, etal., Diabetes Res Clin Pract. 1998 Jan;39(1):3-9.
25.
Expression of adenosine receptors in the preglomerular microcirculation.
Jackson EK, etal., Am J Physiol Renal Physiol 2002 Jul;283(1):F41-51.
26.
Adenosine A1 receptor-mediated presynaptic inhibition of GABAergic transmission in immature rat hippocampal CA1 neurons.
Jeong HJ, etal., J Neurophysiol. 2003 Mar;89(3):1214-22.
27.
Administration of phosphodiesterase inhibitors and an adenosine A1 receptor antagonist induces phrenic nerve recovery in high cervical spinal cord injured rats.
Kajana S and Goshgarian HG, Exp Neurol. 2008 Apr;210(2):671-80. Epub 2008 Jan 5.
28.
Activation of p38 mitogen-activated protein kinase is required for in vivo brain-derived neurotrophic factor production in the rat hippocampus.
Katoh-Semba R, etal., Neuroscience. 2009 Sep 29;163(1):352-61. Epub 2009 Jun 10.
29.
Contribution of NO, ATP-sensitive K+ channels and prostaglandins to adenosine receptor agonists-induced relaxation of the rat tail artery.
Kedzior K, etal., Pharmacol Rep. 2009 Mar-Apr;61(2):330-4.
30.
Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma.
Kim SH, etal., Respir Med. 2009 Mar;103(3):356-63. Epub 2008 Nov 18.
31.
Adenosine A(1) receptor-mediated presynaptic inhibition at the calyx of Held of immature rats.
Kimura M, etal., J Physiol. 2003 Dec 1;553(Pt 2):415-26. doi: 10.1113/jphysiol.2003.048371. Epub 2003 Sep 8.
32.
Adenosine A1 receptor down-regulation in mothers and fetal brain after caffeine and theophylline treatments to pregnant rats.
Leon D, etal., J Neurochem 2002 Aug;82(3):625-34.
33.
Tonic activity of the rat adipocyte A1-adenosine receptor.
Liang HX, etal., Br J Pharmacol. 2002 Mar;135(6):1457-66.
34.
Antiadrenergic effects of adenosine A(1) receptor-mediated protein phosphatase 2a activation in the heart.
Liu Q and Hofmann PA, Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1314-21.
35.
Cloning and expression of an A1 adenosine receptor from rat brain.
Mahan LC, etal., Mol Pharmacol 1991 Jul;40(1):1-7.
36.
Sleep fragmentation impairs ventilatory long-term facilitation via adenosine A1 receptors.
McGuire M, etal., J Physiol. 2008 Nov 1;586(Pt 21):5215-29. Epub 2008 Sep 11.
37.
Effects on sleep of microdialysis of adenosine A1 and A2a receptor analogs into the lateral preoptic area of rats.
Methippara MM, etal., Am J Physiol Regul Integr Comp Physiol. 2005 Dec;289(6):R1715-23. Epub 2005 Aug 18.
38.
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.
Metra M, etal., Eur Heart J. 2011 Mar 8.
39.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
40.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
41.
Adenosine receptor A1 regulates polymorphonuclear cell trafficking and microvascular permeability in lipopolysaccharide-induced lung injury.
Ngamsri KC, etal., J Immunol. 2010 Oct 1;185(7):4374-84. Epub 2010 Aug 20.
42.
Mechanisms of interaction between adenosine receptor subtypes on hippocampal serotonin release
Okada M, etal., Nihon Shinkei Seishin Yakurigaku Zasshi 2002 Apr;22(2):61-9.
43.
Truncation of the A1 adenosine receptor reveals distinct roles of the membrane-proximal carboxyl terminus in receptor folding and G protein coupling.
Pankevych H, etal., J Biol Chem. 2003 Aug 8;278(32):30283-93. Epub 2003 May 22.
44.
Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure.
Perlini S, etal., J Hypertens. 2007 Feb;25(2):449-54.
45.
Differential expression of adenosine A1 and A2A receptors after upper cervical (C2) spinal cord hemisection in adult rats.
Petrov T, etal., J Spinal Cord Med. 2007;30(4):331-7.
46.
Expression cloning of rat cerebellar adenosine A1 receptor by coupling to Kir channels.
Pfaff T and Karschin A, Neuroreport 1997 Jul 28;8(11):2455-60.
47.
Subcellular distributions of adenosine A1 and A2A receptors in the rat dorsomedial nucleus of the solitary tract at the level of the area postrema.
Pickel VM, etal., Synapse. 2006 Dec 1;60(7):496-509.
48.
Neuroinflammation after neonatal hypoxia-ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most predominant after insult.
Pimentel VC, etal., Mol Cell Biochem. 2015 May;403(1-2):169-77. doi: 10.1007/s11010-015-2347-9. Epub 2015 Feb 27.
49.
Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder.
Pires VA, etal., Behav Pharmacol. 2009 Mar;20(2):134-45.
50.
Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma.
Ponnoth DS, etal., Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H81-7. Epub 2010 Apr 16.
51.
Short-term metabolic and haemodynamic effects of GR79236 in normal and fructose-fed rats.
Qu X, etal., Eur J Pharmacol. 1997 Nov 12;338(3):269-76.
52.
Subcellular localization of adenosine A(1) receptors in nerve terminals and synapses of the rat hippocampus.
Rebola N, etal., Brain Res. 2003 Oct 10;987(1):49-58.
53.
Adenosine-regulated cell proliferation in pituitary folliculostellate and endocrine cells: differential roles for the A(1) and A(2B) adenosine receptors.
Rees DA, etal., Endocrinology 2002 Jun;143(6):2427-36.
54.
A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity.
Regan SE, etal., Am J Physiol Heart Circ Physiol. 2003 Mar;284(3):H859-66.
55.
GOA pipeline
RGD automated data pipeline
56.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
57.
The heat shock cognate protein hsc73 assembles with A(1) adenosine receptors to form functional modules in the cell membrane.
Sarrio S, etal., Mol Cell Biol. 2000 Jul;20(14):5164-74.
58.
Characterization of adenosine-A1 receptor-mediated antilipolysis in rats by tissue microdialysis, 1H-spectroscopy, and glucose clamp studies.
Schoelch C, etal., Diabetes. 2004 Jul;53(7):1920-6.
59.
The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats.
Schrier DJ, etal., J Immunol. 1990 Sep 15;145(6):1874-9.
60.
Mechanisms mediating regional sympathoactivatory responses to stimulation of NTS A(1) adenosine receptors.
Scislo TJ and O'Leary DS, Am J Physiol Heart Circ Physiol 2002 Oct;283(4):H1588-99.
61.
A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury.
Sun CX, etal., J Clin Invest. 2005 Jan;115(1):35-43.
62.
Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors.
Sun D, etal., Proc Natl Acad Sci U S A 2001 Aug 14;98(17):9983-8.
63.
Effects of adenosine A1 receptor antagonism on lipogenesis and lipolysis in isolated rat adipocytes.
Szkudelski T, etal., Physiol Res. 2009;58(6):863-71. Epub 2008 Dec 17.
64.
Tentative Sequence Identification Numbers
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
65.
A1 adenosine receptor activation induces ventriculomegaly and white matter loss.
Turner CP, etal., Neuroreport. 2002 Jul 2;13(9):1199-204.
66.
A new adenosine subtype-1 receptor antagonist, FK-838, attenuates salt-induced hypertension in Dahl salt-sensitive rats.
Uehara Y, etal., Am J Hypertens. 1995 Dec;8(12 Pt 1):1189-99.
67.
Adenosine A(1) receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus.
Vallon V, etal., Nephron Physiol. 2009;111(3):p30-8. Epub 2009 Mar 10.
68.
The role of adenosine in the early respiratory and cardiovascular changes evoked by chronic hypoxia in the rat.
Walsh MP and Marshall JM, J Physiol. 2006 Aug 15;575(Pt 1):277-89. Epub 2006 May 11.
69.
The role of adenosine-related genes variants in susceptibility to essential hypertension.
Wright K, etal., J Hypertens. 2004 Aug;22(8):1519-22.
70.
Adenosine A(1) receptor-mediated transactivation of the EGF receptor produces a neuroprotective effect on cortical neurons in vitro.
Xie KQ, etal., Acta Pharmacol Sin. 2009 Jul;30(7):889-98.
71.
Adenosine A(1) receptors selectively target protein kinase C isoforms to the caveolin-rich plasma membrane in cardiac myocytes.
Yang Z, etal., Biochim Biophys Acta. 2009 Dec;1793(12):1868-75. Epub 2009 Oct 30.
72.
Role of adenosine A1 receptor in the regulation of gastrin release.
Yip L, etal., J Pharmacol Exp Ther. 2004 Aug;310(2):477-87. Epub 2004 Mar 24.
73.
Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells.
Yoshioka K, etal., FEBS Lett. 2002 Jul 17;523(1-3):147-51.
74.
Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains.
Yoshioka K, etal., FEBS Lett. 2002 Nov 6;531(2):299-303.
75.
Heteromeric association creates a P2Y-like adenosine receptor.
Yoshioka K, etal., Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7617-22. Epub 2001 Jun 5.
76.
Adenosine-stimulated atrial natriuretic peptide release through A1 receptor subtype.
Yuan K, etal., Hypertension. 2005 Dec;46(6):1381-7. Epub 2005 Nov 14.
77.
Role of renal medullary adenosine in the control of blood flow and sodium excretion.
Zou AP, etal., Am J Physiol 1999 Mar;276(3 Pt 2):R790-8.
78.
Effect of chronic salt loading on adenosine metabolism and receptor expression in renal cortex and medulla in rats.
Zou AP, etal., Hypertension 1999 Jan;33(1 Pt 2):511-6.
Adora1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 13 48,210,922 - 48,247,826 (-) NCBI GRCr8 mRatBN7.2 13 45,658,872 - 45,695,821 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 13 45,658,872 - 45,695,801 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 13 48,270,569 - 48,302,744 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 13 49,558,626 - 49,590,806 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 13 46,823,488 - 46,855,595 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 13 51,042,111 - 51,076,913 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 51,042,248 - 51,076,852 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 13 56,097,883 - 56,132,155 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 47,160,292 - 47,192,804 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 13 47,173,084 - 47,207,198 (-) NCBI Celera 13 45,990,556 - 46,022,753 (-) NCBI Celera Cytogenetic Map 13 q13 NCBI
ADORA1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 203,127,726 - 203,167,405 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 203,090,654 - 203,167,405 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 203,096,854 - 203,136,533 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 201,363,459 - 201,403,156 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 199,791,438 - 199,868,189 NCBI Celera 1 176,226,082 - 176,265,774 (+) NCBI Celera Cytogenetic Map 1 q32.1 NCBI HuRef 1 174,262,408 - 174,301,662 (+) NCBI HuRef CHM1_1 1 204,519,171 - 204,558,852 (+) NCBI CHM1_1 T2T-CHM13v2.0 1 202,390,478 - 202,430,156 (+) NCBI T2T-CHM13v2.0
Adora1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 1 134,126,953 - 134,163,195 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 1 134,126,963 - 134,163,169 (-) Ensembl GRCm39 Ensembl GRCm38 1 134,199,215 - 134,235,457 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 1 134,199,223 - 134,235,431 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 1 136,095,799 - 136,132,008 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 1 136,015,633 - 136,051,842 (-) NCBI MGSCv36 mm8 Celera 1 136,811,737 - 136,847,932 (-) NCBI Celera Cytogenetic Map 1 E4 NCBI cM Map 1 58.15 NCBI
Adora1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955406 39,149,689 - 39,187,688 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955406 39,148,811 - 39,183,577 (+) NCBI ChiLan1.0 ChiLan1.0
ADORA1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 46,210,718 - 46,250,302 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 46,178,264 - 46,216,877 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 178,728,751 - 178,769,066 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 183,023,466 - 183,063,760 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 183,023,466 - 183,063,760 (+) Ensembl panpan1.1 panPan2
ADORA1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 7 44,819 - 74,217 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 7 44,820 - 73,051 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 7 100,548 - 128,787 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 7 55,302 - 84,711 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 7 55,305 - 83,603 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 7 43,539 - 71,770 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 7 153,116 - 181,315 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 7 175,551 - 203,789 (-) NCBI UU_Cfam_GSD_1.0
Adora1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024409344 72,195,448 - 72,227,851 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936567 1,429,817 - 1,462,532 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936567 1,430,128 - 1,508,626 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
ADORA1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 9 113,835,921 - 113,872,365 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 9 113,835,279 - 113,875,899 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 9 125,293,656 - 125,331,581 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
ADORA1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 25 26,180,898 - 26,221,424 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 25 26,182,446 - 26,220,776 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666055 26,957,323 - 26,997,269 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Adora1 (Heterocephalus glaber - naked mole-rat)
.
Confirmed Target Of
Mir150 rno-miR-150-5p Mirtarbase external_info Microarray Functional MTI (Weak) 18258830
Predicted Target Of
Count of predictions: 223 Count of miRNA genes: 139 Interacting mature miRNAs: 167 Transcripts: ENSRNOT00000004602 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
10755495 Bp387 Blood pressure QTL 387 3.78 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 34663461 87525369 Rat 9589141 Insul28 Insulin level QTL 28 10.82 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 13 9313465 54313465 Rat 12879436 Bp395 Blood pressure QTL 395 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 44639182 45700190 Rat 6893344 Cm79 Cardiac mass QTL 79 1.5 0.04 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 13 43720770 62022792 Rat 70220 Bp55 Blood pressure QTL 55 5.75 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 13 37374509 82374509 Rat 61391 Bp5 Blood pressure QTL 5 5.6 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 13 22301875 67301875 Rat 4889861 Pur29 Proteinuria QTL 29 13.8 0.005 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 13 37415584 80753406 Rat 2317040 Aia21 Adjuvant induced arthritis QTL 21 2.75 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 13 9831541 54831541 Rat 631645 Bp121 Blood pressure QTL 121 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 14915655 59915655 Rat 2317046 Aia8 Adjuvant induced arthritis QTL 8 3.9700000286102295 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 13 9831541 54831541 Rat 619615 Bp80 Blood pressure QTL 80 0.0354 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 39754544 84754544 Rat 1581570 Eae17 Experimental allergic encephalomyelitis QTL 17 4.1 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 13 8897350 101631289 Rat 70170 Eae14 Experimental allergic encephalomyelitis QTL 14 0.0024 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 13 23203448 68203448 Rat 1331784 Bp222 Blood pressure QTL 222 2.944 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 17694436 53050594 Rat 61340 Bp25 Blood pressure QTL 25 4.2 0.004 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 34535218 79535218 Rat 1581573 Uae36 Urinary albumin excretion QTL 36 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 13 5994833 77046787 Rat 1549897 Stresp12 Stress response QTL 12 3.35 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 13 38433408 83433408 Rat 2302275 Gluco37 Glucose level QTL 37 3.8 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 13 11929449 46193066 Rat 7207885 Glom27 Glomerulus QTL 27 3.9 kidney glomerulus integrity trait (VT:0010546) kidney crescentic glomeruli count to kidney normal glomeruli count ratio (CMO:0002139) 13 20605871 101339738 Rat 4145117 Mcs27 Mammary carcinoma susceptibility QTL 27 0.0001 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 13 43437904 47841255 Rat 1558644 Cm45 Cardiac mass QTL 45 3.6 0.002 heart mass (VT:0007028) heart wet weight (CMO:0000069) 13 23692969 68692969 Rat 70181 BpQTLcluster11 Blood pressure QTL cluster 11 6.922 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 13 31241331 93395974 Rat 61349 Bp31 Blood pressure QTL 31 5.75 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 13 37374509 82374509 Rat 2303563 Bw89 Body weight QTL 89 6 body mass (VT:0001259) body weight (CMO:0000012) 13 32284471 77284471 Rat 1354621 Rf47 Renal function QTL 47 3.7 kidney renin amount (VT:0010559) kidney renin level (CMO:0002166) 13 30395351 101056920 Rat 2301962 Cm72 Cardiac mass QTL 72 4.12 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 13 31241331 58363171 Rat 1581554 Pur11 Proteinuria QTL 11 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 13 5994833 77046787 Rat 12879477 Bp401 Blood pressure QTL 401 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 37262092 82262092 Rat 1331750 Bp220 Blood pressure QTL 220 2.98 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 13 37415584 82415584 Rat 6893338 Cm76 Cardiac mass QTL 76 0 0.99 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 13 23692969 68692969 Rat 12879472 Bp399 Blood pressure QTL 399 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 45228358 47841255 Rat 1354666 Bp244 Blood pressure QTL 244 4.9 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 1 101056920 Rat 9589164 Gluco66 Glucose level QTL 66 6.67 0.001 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 13 15158722 60158722 Rat 7411662 Foco29 Food consumption QTL 29 20.8 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 13 9313465 54313465 Rat
D13Hmgc03
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 13 45,689,077 - 45,689,314 (+) MAPPER mRatBN7.2 Rnor_6.0 13 51,070,083 - 51,070,319 NCBI Rnor6.0 Rnor_5.0 13 56,125,418 - 56,125,654 UniSTS Rnor5.0 RGSC_v3.4 13 47,187,081 - 47,187,317 UniSTS RGSC3.4 Celera 13 46,017,042 - 46,017,266 UniSTS Cytogenetic Map 13 q13 UniSTS
BB176431
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 13 48,213,949 - 48,214,049 (+) Marker Load Pipeline mRatBN7.2 13 45,661,914 - 45,662,013 (+) MAPPER mRatBN7.2 Rnor_6.0 13 51,042,925 - 51,043,023 NCBI Rnor6.0 Rnor_5.0 13 56,098,605 - 56,098,703 UniSTS Rnor5.0 RGSC_v3.4 13 47,159,719 - 47,159,817 UniSTS RGSC3.4 Celera 13 45,989,983 - 45,990,081 UniSTS Cytogenetic Map 13 q13 UniSTS
UniSTS:141040
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 13 45,662,660 - 45,662,839 (+) MAPPER mRatBN7.2 Rnor_6.0 13 51,043,671 - 51,043,849 NCBI Rnor6.0 Rnor_5.0 13 56,099,351 - 56,099,529 UniSTS Rnor5.0 RGSC_v3.4 13 47,160,465 - 47,160,643 UniSTS RGSC3.4 Celera 13 45,990,729 - 45,990,907 UniSTS Cytogenetic Map 13 q13 UniSTS
This gene Adora1 is modified in the following models/strains:
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
87
86
55
25
55
6
214
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000004602 ⟹ ENSRNOP00000004602
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 13 45,658,872 - 45,695,801 (-) Ensembl Rnor_6.0 Ensembl 13 51,042,248 - 51,076,165 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000078993 ⟹ ENSRNOP00000073958
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 13 51,043,334 - 51,076,852 (-) Ensembl
RefSeq Acc Id:
NM_017155 ⟹ NP_058851
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 48,214,523 - 48,246,831 (-) NCBI mRatBN7.2 13 45,662,488 - 45,694,801 (-) NCBI Rnor_6.0 13 51,043,498 - 51,075,806 (-) NCBI Rnor_5.0 13 56,097,883 - 56,132,155 (-) NCBI RGSC_v3.4 13 47,160,292 - 47,192,804 (-) RGD Celera 13 45,990,556 - 46,022,753 (-) RGD
Sequence:
CCTTGGGTGCTGGCCTCGTGCCCCAGGGCGCCTGTCTGCTGATGTGCCCAGCTCCTGCCCACCATGCCGCCCTACATCTCGGCCTTCCAGGCTGCCTACATTGGCATCGAGGTGCTCATTGCCTTGGT CTCTGTGCCCGGAAATGTACTGGTGATTTGGGCTGTGAAGGTGAACCAGGCACTTCGCGATGCCACCTTCTGCTTCATCGTGTCACTGGCGGTAGCTGATGTGGCCGTTGGCGCCCTGGTCATCCCAC TGGCCATCCTTATCAACATTGGGCCACAGACCTACTTCCACACCTGCCTCATGGTGGCCTGCCCTGTCCTCATCCTCACCCAGAGCTCCATTCTGGCTCTGCTCGCCATTGCTGTGGATCGATACCTC CGAGTCAAGATCCCTCTCCGGTACAAGACAGTGGTGACCCAGCGGCGGGCGGCAGTGGCCATAGCTGGCTGCTGGATTCTCTCCCTTGTGGTAGGCCTGACACCCATGTTTGGCTGGAACAACCTGAG TGTGGTAGAGCAAGACTGGAGAGCCAACGGCAGTGTTGGGGAGCCCGTGATCAAGTGTGAGTTTGAGAAGGTTATCAGCATGGAGTACATGGTCTACTTCAACTTCTTCGTCTGGGTGCTGCCGCCAC TGCTCCTCATGGTCCTCATCTACCTGGAGGTCTTCTACCTGATCCGTAAGCAGCTCAACAAAAAGGTGTCAGCCTCCTCCGGTGACCCCCAGAAGTACTACGGGAAGGAGCTGAAGATCGCCAAGTCG CTGGCCCTCATCCTCTTCCTCTTTGCCCTCAGCTGGCTGCCGCTGCATATCTTGAACTGTATCACCCTCTTCTGCCCCACCTGCCAGAAACCCAGCATTCTGATCTACATCGCCATCTTCCTCACACA CGGCAACTCCGCCATGAACCCCATCGTCTATGCCTTCCGGATCCACAAGTTCCGGGTCACCTTTCTGAAGATTTGGAATGACCACTTCCGATGCCAGCCTAAGCCTCCCATCGATGAAGACCTCCCAG AGGAGAAAGCTGAGGACTAGACTCTGCCTTGCTCCGTCTAGCCCATGCCCAGCGG
hide sequence
RefSeq Acc Id:
XM_006249859 ⟹ XP_006249921
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 48,210,922 - 48,247,804 (-) NCBI mRatBN7.2 13 45,658,872 - 45,695,821 (-) NCBI Rnor_6.0 13 51,042,111 - 51,076,906 (-) NCBI Rnor_5.0 13 56,097,883 - 56,132,155 (-) NCBI
Sequence:
ACGGAGGGCGACGAGGGAGGGGCCCGCGAGTGCCGCCGCCGCCCCCGCCCCCTCCCTCTCCGGT GTGCGGAGCCCGATTGTCACTCAGCTCCCGCGCCGGGGGCGACGAAGGCGCGGGCGCCAGAGTGGAGTCTCGGCTGGCTACCACCCCCTGGACCTAACTGGGTAACCCTGGGTTCCCCTGGCATCCTC TGAGTGAGCGACTGCCCAAGGTTTCGAGGTCTAGGGATACTTGGCTAGACTGTTCAGGTGGCCAGGAGCTCTGCCAGCTTTGGTGTGACCTTGGGGCTGCCTATGTTCCCCTCCTTCCCAGGCTGGCA TCCCCACCGCAGGCTTCCTGACCACAGGTGCTGGCCTCGTGCCCCAGGGCGCCTGTCTGCTGATGTGCCCAGCTCCTGCCCACCATGCCGCCCTACATCTCGGCCTTCCAGGCTGCCTACATTGGCAT CGAGGTGCTCATTGCCTTGGTCTCTGTGCCCGGAAATGTACTGGTGATTTGGGCTGTGAAGGTGAACCAGGCACTTCGCGATGCCACCTTCTGCTTCATCGTGTCACTGGCGGTAGCTGATGTGGCCG TTGGCGCCCTGGTCATCCCACTGGCCATCCTTATCAACATTGGGCCACAGACCTACTTCCACACCTGCCTCATGGTGGCCTGCCCTGTCCTCATCCTCACCCAGAGCTCCATTCTGGCTCTGCTCGCC ATTGCTGTGGATCGATACCTCCGAGTCAAGATCCCTCTCCGGTACAAGACAGTGGTGACCCAGCGGCGGGCGGCAGTGGCCATAGCTGGCTGCTGGATTCTCTCCCTTGTGGTAGGCCTGACACCCAT GTTTGGCTGGAACAACCTGAGTGTGGTAGAGCAAGACTGGAGAGCCAACGGCAGTGTTGGGGAGCCCGTGATCAAGTGTGAGTTTGAGAAGGTTATCAGCATGGAGTACATGGTCTACTTCAACTTCT TCGTCTGGGTGCTGCCGCCACTGCTCCTCATGGTCCTCATCTACCTGGAGGTCTTCTACCTGATCCGTAAGCAGCTCAACAAAAAGGTGTCAGCCTCCTCCGGTGACCCCCAGAAGTACTACGGGAAG GAGCTGAAGATCGCCAAGTCGCTGGCCCTCATCCTCTTCCTCTTTGCCCTCAGCTGGCTGCCGCTGCATATCTTGAACTGTATCACCCTCTTCTGCCCCACCTGCCAGAAACCCAGCATTCTGATCTA CATCGCCATCTTCCTCACACACGGCAACTCCGCCATGAACCCCATCGTCTATGCCTTCCGGATCCACAAGTTCCGGGTCACCTTTCTGAAGATTTGGAATGACCACTTCCGATGCCAGCCTAAGCCTC CCATCGATGAAGACCTCCCAGAGGAGAAAGCTGAGGACTAGACTCTGCCTTGCTCCGTCTAGCCCATGCCCAGCGGCTCTCTGTTCAACTCCCACGTCCTCCCTGTCCCACCCTGTCCCACTGTCCCT CCTCAGTTTTCCCAGCTGGGGTGTAGGCTGTGGACACCAGGGAGGCTCTGAAGAGATACCATGGAATAGGGCCCCCCTATAAGGAGCTAGCTGCCCTGTACTTGGGGACCCGGAGGAGGCTTGGAGGT GGGGCGGGCTATGATAGGGAACTGGGTGCCCTGAGATGTGAGGAGAGTCTTGTGTGCCCCATCCCTGGCTGTTCTCTGAGCTGTTCAGAGAGCCAGGGTTAGAATATTCTGGCTCCTACAGTCAGGCA GGGAGGGGAGCCTGCTATTAGGTGTTGGTGGCCCGAGGGACCAACTTCAAGGTGAGAAAGACAGTCCCTTAGAGGTAAATGGATAGAGAGAGGATATGTCCTGGCTTTGCTGTCTCTCCTCTTCTGTA GGAGAAGACAGTAAATCACAGGGAAGGAGACCTCAGCCCCTCCTCCAAGGATTGTGTGCTTGGCCATGCAGGCGCTGTGGTACCTGCTTTCCTCACCTGGGCTTATACTTGGGAGAGGCAGAAAGAAT GGGTCCAGGGATCCTCTCACATTTACTTTATTCACATCCTGGCCCTCAAAGTGGGCCACAAAGTCCTTGGGAATAAAAATAGTGCAGAAGGTGCTGGCTTCAGCTAGCCAGCAGGGAGCAGCACTGAG CCCTTCTTGCCCTGAACTTCCTGGGAGTCCCCAGTGTAATTTACTGTCTGGGGCACCAAGCTTCACCAACTCTCAGAGCAGGCCTGGACTCTCCTTCCAAGGCCCAGGAGAAGGGATCCCTGGGAAGG ACAACCCTTGGGAGCATGCTGCCTGAGGGGGTAGGAGGGGAAAGCGTCCAAGGAGATCCCAGGCGACCGTGGGCACCCTTGGTGTGAAGTGTGACAGGTCAGACCAGACCAAAGGAGACTGCTGTCTT CAGTGTGAGGAAGTGCCTTGCTGGCATTTAAATATCCAAAAAAATGCTCCTGGAGGTGGATTTAGCTCAGAAGCTGTGTTACAAATAGAGTGTAGGCTTTTGGGAGGGTCTCAGATAGGACCAATCCC TACTCTGCTGAGCCTGGATGTCTTCCTTGTATGGACGGCAGGCAGAGGAGGGTGACAGGTTCTGAGTGTGAATATCGACTCCAAGTCTTGATTCTGGGCTCTTCCCTCAGTTGGAAGCAAGGTGTCCC TGGTTCTCAAGGAGGTCCCTATGTCTAATAAAAGATTGTGAACCCCTGTGGAGAGTGGGGTGCTGGCACCCCAGCACTGTCAGAAAGCAACCAGACCACCTCAGTGGAGAAGATGTAATGGTGGGGTT GGGGGAGAAGCTGGGAGATGGGCGTGGTGGCAGATGGAAAAAGGAAGGTTCCAGA
hide sequence
RefSeq Acc Id:
XM_039090617 ⟹ XP_038946545
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 48,210,922 - 48,247,293 (-) NCBI mRatBN7.2 13 45,658,872 - 45,695,595 (-) NCBI
RefSeq Acc Id:
XM_039090618 ⟹ XP_038946546
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 48,210,922 - 48,247,804 (-) NCBI mRatBN7.2 13 45,658,872 - 45,695,821 (-) NCBI
RefSeq Acc Id:
XM_039090619 ⟹ XP_038946547
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 48,210,922 - 48,247,293 (-) NCBI mRatBN7.2 13 45,658,872 - 45,695,596 (-) NCBI
RefSeq Acc Id:
XM_039090620 ⟹ XP_038946548
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 48,210,922 - 48,247,826 (-) NCBI mRatBN7.2 13 45,658,872 - 45,695,821 (-) NCBI
RefSeq Acc Id:
XM_063272203 ⟹ XP_063128273
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 48,210,922 - 48,247,294 (-) NCBI
RefSeq Acc Id:
NP_058851 ⟸ NM_017155
- UniProtKB:
P25099 (UniProtKB/Swiss-Prot), A6ICB1 (UniProtKB/TrEMBL), O08766 (UniProtKB/TrEMBL)
- Sequence:
MPPYISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKTVVTQRRAAVAI AGCWILSLVVGLTPMFGWNNLSVVEQDWRANGSVGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCI TLFCPTCQKPSILIYIAIFLTHGNSAMNPIVYAFRIHKFRVTFLKIWNDHFRCQPKPPIDEDLPEEKAED
hide sequence
RefSeq Acc Id:
XP_006249921 ⟸ XM_006249859
- Peptide Label:
isoform X1
- Sequence:
MPPYISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKTVVTQRRAAVAI AGCWILSLVVGLTPMFGWNNLSVVEQDWRANGSVGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCI TLFCPTCQKPSILIYIAIFLTHGNSAMNPIVYAFRIHKFRVTFLKIWNDHFRCQPKPPIDEDLPEEKAED
hide sequence
Ensembl Acc Id:
ENSRNOP00000004602 ⟸ ENSRNOT00000004602
Ensembl Acc Id:
ENSRNOP00000073958 ⟸ ENSRNOT00000078993
RefSeq Acc Id:
XP_038946548 ⟸ XM_039090620
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_038946546 ⟸ XM_039090618
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_038946547 ⟸ XM_039090619
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_038946545 ⟸ XM_039090617
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_063128273 ⟸ XM_063272203
- Peptide Label:
isoform X1
RGD ID: 13698833
Promoter ID: EPDNEW_R9352
Type: multiple initiation site
Name: Adora1_1
Description: adenosine A1 receptor
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 13 51,076,239 - 51,076,299 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2002-11-06
Adora1
adenosine A1 receptor
adenosine A1 receptor
Name updated
625702
APPROVED
2002-06-10
Adora1
adenosine A1 receptor
Symbol and Name status set to approved
70586
APPROVED
Note Type
Note
Reference
gene_drugs
8-cyclopentyl-1,3-dipropylxanthine (DPCPX) increases urine flow and sodium excretion
628573
gene_expression
expressed in the cerebellum
631744
gene_expression
expressed in many regions of the brain including cortex, cerebellum, hippocampus, and thalamus
69743
gene_expression
distributed along nephron and in outer medullary desceding vasa recta; localized to specific nephron segments, including glomeruli, thick ascending limb and papillary collecting duct
628573
gene_expression
expressed in renal cortex and medulla
628573
gene_expression
protein and mRNA expressed at high levels in the preglomerular microvessels (PGMVs) of kidney
628573
gene_function
inhibits adenylyl cyclase activity
69743
gene_function
antidiuretic and antinatriuretic adenosine receptor
628573
gene_process
involved in the regulation of arterial pressure and heart rate
631806
gene_process
plays a role in adaptation in the kidney to promote sodium excretion
628562
gene_process
administration of agonists cause vasoconstriction of the preglomerular microvessels (PGMVs) and potentiation of angiotensin II-induced changes in renal vascular resistance, reduction of the glomerular filtration rate and inhibition renin release
628573
gene_process
may mediate antinatriuretic effects of adenosine
628573
gene_product
member of the G-protein coupled receptor family
631744
gene_protein
encodes a protein sequence of 326 amino acids
631744
gene_protein
38 kDa
628351
gene_protein
39 kDa
628573
gene_regulation
a high salt diet (4% NaCl for 3 weeks) decreases mRNA expression
628573
gene_transcript
mRNA transcripts of 5.6 and 3.1 kb are detected
69743